Syros Pharmaceuticals (SYRS) Insider Trading & Ownership $0.03 0.00 (-1.94%) As of 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Syros Pharmaceuticals (NASDAQ:SYRS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.26%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$206,490.57Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$225,493.85 Get SYRS Insider Trade Alerts Want to know when executives and insiders are buying or selling Syros Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SYRS Insider Buying and Selling by Quarter Remove Ads Syros Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/2/2024Nancy A SimonianDirectorSell37,070$0.27$10,008.90 11/25/2024Nancy A SimonianDirectorSell134,713$0.27$36,372.51 9/12/2024Jason HaasCFOBuy45,344$1.68$76,177.92 9/10/2024Conley CheeCEOBuy50,000$1.51$75,500.00 9/10/2024Jason HaasCFOBuy35,363$1.55$54,812.65 6/28/2024Richard A YoungDirectorSell34,837$5.12$178,365.44 4/2/2024David RothInsiderSell150$4.98$747.00 (Data available from 1/1/2013 forward) SYRS Insider Trading Activity - Frequently Asked Questions Who is on Syros Pharmaceuticals's Insider Roster? The list of insiders at Syros Pharmaceuticals includes Conley Chee, David Roth, Eric R Olson, Jason Haas, Nancy A Simonian, Richard A Young, Srinivas Akkaraju, and Timothy Tyson. Learn more on insiders at SYRS. What percentage of Syros Pharmaceuticals stock is owned by insiders? 12.26% of Syros Pharmaceuticals stock is owned by insiders. Learn more on SYRS's insider holdings. Which Syros Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SYRS shares in the last 24 months: Conley Chee ($75,500.00), Jason Haas ($130,990.57), and Srinivas Akkaraju ($3,999,998.34). How much insider buying is happening at Syros Pharmaceuticals? Insiders have purchased a total of 1,035,684 SYRS shares in the last 24 months for a total of $4,206,488.91 bought. Which Syros Pharmaceuticals insiders have been selling company stock? The following insiders have sold SYRS shares in the last 24 months: David Roth ($54,605.25), Eric R Olson ($2,411.50), Nancy A Simonian ($46,381.41), and Richard A Young ($178,365.44). How much insider selling is happening at Syros Pharmaceuticals? Insiders have sold a total of 221,094 Syros Pharmaceuticals shares in the last 24 months for a total of $281,763.60 sold. Syros Pharmaceuticals Key ExecutivesMr. Conley Chee (Age 54)CEO, President & Director Compensation: $672.24kDr. Richard A. Young Ph.D. (Age 70)Scientific Founder, Member of Scientific Advisory Board & Director Compensation: $51.75kMr. Jason Haas (Age 56)Chief Financial Officer Compensation: $672.22kDr. David A. Roth M.D. (Age 61)Chief Medical Officer Compensation: $715.73kDr. James E. Bradner M.D. (Age 52)Founder Dr. Nathanael S. Gray Ph.D.Scientific Founder & Member of Scientific Advisory BoardMs. Karen Hunady M.S.Director of Corporate Communications & Investor RelationsMr. Gerald E. Quirk Esq. (Age 56)J.D., Chief Legal Officer & Head of Business Development Compensation: $127.07kMs. Lisa RobertsVice President of Human ResourcesMs. Kristin Stephens (Age 51)Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies Sonnet BioTherapeutics Insider Transactions Evoke Pharma Insider Transactions CNS Pharmaceuticals Insider Transactions Titan Pharmaceuticals Insider Transactions 180 Life Sciences Insider Transactions Synaptogenix Insider Transactions InMed Pharmaceuticals Insider Transactions Artelo Biosciences Insider Transactions Conduit Pharmaceuticals Insider Transactions Oragenics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:SYRS) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SYRS Stock Free SYRS Stock Alerts